Schedule of Basic and Diluted Net Loss per Share |
Basic and diluted net income per share were as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Thirteen Weeks Ended | | Twenty-Six Weeks Ended | (in thousands, except per share data) | June 28, 2025 | | June 29, 2024 | | June 28, 2025 | | June 29, 2024 | Numerator | | | | | | | | Net income | $ | 18,917 | | | $ | 9,712 | | | $ | 14,194 | | | $ | 9,245 | | Denominator | | | | | | | | Basic weighted average shares outstanding | 156,464 | | 161,788 | | 157,524 | | 161,518 | Dilutive effect of employee stock options and awards | 5,929 | | 6,222 | | 5,773 | | 6,502 | Diluted weighted average shares outstanding (1) | 162,393 | | 168,010 | | 163,297 | | 168,020 | Net income per share | | | | | | | | Basic | $ | 0.12 | | | $ | 0.06 | | | $ | 0.09 | | | $ | 0.06 | | Diluted | $ | 0.12 | | | $ | 0.06 | | | $ | 0.09 | | | $ | 0.06 | |
(1)For the thirteen and twenty-six weeks ended June 28, 2025, the calculation of diluted net income per share excludes the effect of 8.2 million and 7.6 million, respectively, of potential shares of common stock relating to awards of stock options and restricted stock units that, if exercised or vested, would have been antidilutive. For the thirteen and twenty-six weeks ended June 29, 2024, the calculation of diluted net income per share excludes the effect of 3.5 million and 2.4 million, respectively, of potential shares of common stock relating to awards of stock options and restricted stock units that, if exercised or vested, would have been antidilutive.
|